June 25, 2020 10:48 AM EDT
News Briefing

CRISPR Ther­a­peu­tics blue­prints cell ther­a­py man­u­fac­tur­ing site; Re­gen­eron fights back against kick­back claims

John Carroll

Editor & Founder

→ CRISPR Ther­a­peu­tics $CR­SP is join­ing the rush to build out a new cell ther­a­py man­u­fac­tur­ing space. The biotech re­ports that it is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times